Skip to main content
Supplement ScienceSupplementScience

DIM (Diindolylmethane) Research & Evidence

·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Evidence Level

Moderate

DIM has moderate clinical evidence supporting its role in estrogen metabolism. A key 2004 study by Dalessandri et al. demonstrated that 108mg of absorption-enhanced DIM daily significantly increased the urinary 2:16-hydroxyestrone ratio in postmenopausal women. Additional research in cervical dysplasia (Del Priore et al., 2010) showed some benefit. While mechanistic data is strong, large-scale RCTs are still needed to confirm clinical endpoints.

Evidence by Condition

ConditionStudied DoseEvidence
Estrogen metabolism support100-200mg dailyModerate
Cervical health150-300mg dailyEmerging
Prostate health100-200mg dailyEmerging
Full DIM (Diindolylmethane) Guide

References

  1. Dalessandri KM, Firestone GL, Fitch MD, Bradlow HL, Bjeldanes LF (2004). Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer. Nutrition and Cancer. DOI PubMed
  2. Del Priore G, Gudipudi DK, Montemarano N, Restivo AM, Malanowska-Stega J, Arslan AA (2010). Oral diindolylmethane (DIM): pilot evaluation of a nonsurgical treatment for cervical dysplasia. Gynecologic Oncology. DOI PubMed